(Circulation. 1999;100:933-939.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Department of Emergency Medicine, University La Sapienza, Rome (G. Barbaro, G.D.L., M.S., G.G.); the Division of Infectious Diseases, General Hospital, Foggia (B.G.); the 2nd Division of Infectious Diseases, Spallanzani Hospital, Rome (A.P.); and the Department of Infectious and Tropical Diseases, Policlinico S. Matteo, University of Pavia (G. Barbarini), Italy.
Correspondence to Dr Giuseppe Barbaro, MD, Viale Anicio Gallo 63, 00174 Rome, Italy.
BackgroundIncreased
levels of tumor necrosis factor-
(TNF-
) and inducible nitric
oxide synthase (iNOS) have been reported in patients with dilated
cardiomyopathy. We investigated the myocardial
expression of TNF-
and iNOS in patients with HIV-associated
cardiomyopathy (HIV-DCM) compared with patients
with idiopathic dilated cardiomyopathy (IDCM).
Methods and ResultsEndomyocardial
biopsy specimens from 82 HIV-DCM and 80 IDCM patients were processed
for determination of the immunostaining intensity of
TNF-
and iNOS and for virological examination. Negative controls
were derived from autopsy myocardium specimens from 32
HIV-negative patients without known heart disease. The mortality rate
for congestive heart failure between groups according to the intensity
of iNOS staining was also evaluated. The mean intensity of both TNF-
and iNOS staining was greater in patients with HIV-DCM (0.81 and 1.007,
respectively) than in patients with IDCM (0.44 and 0.49, respectively)
and controls (0.025 and 0.027, respectively). The staining intensity of
both TNF-
and iNOS was inversely correlated with CD4 count. The
staining intensity of iNOS was greater in HIV-DCM patients with
HIV/coxsackievirus B3 (CVB3) or with HIV/cytomegalovirus coinfection
than in IDCM patients showing infection with CVB3 and adenovirus alone.
The staining intensity of iNOS correlated to mortality rate, because it
was higher in HIV-DCM patients and, in particular, in those with an
optical density unit >1.
ConclusionsCytokine activation seems to play a significant pathogenetic role in both HIV-DCM and IDCM. In HIV-DCM patients, the state of immunodeficiency may favor the selection of viral variants of increased pathogenicity, influencing the clinical course of cardiomyopathy by enhancement of the inflammatory process.
Key Words: AIDS viruses cardiomyopathy hormones nitric oxide synthase
This article has been cited by other articles:
![]() |
A. J. Lokuta, N. A. Maertz, S. V. Meethal, K. T. Potter, T. J. Kamp, H. H. Valdivia, and R. A. Haworth Increased Nitration of Sarcoplasmic Reticulum Ca2+-ATPase in Human Heart Failure Circulation, March 1, 2005; 111(8): 988 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A Chaves, M. J Mihm, B. L Schanbacher, A. Basuray, C. Liu, L. W Ayers, and J. Anthony Bauer Cardiomyopathy in a murine model of AIDS: evidence of reactive nitrogen species and corroboration in human HIV/AIDS cardiac tissues Cardiovasc Res, October 15, 2003; 60(1): 108 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, G. Davis-Gorman, R. R. Watson, and P. F. McDonagh ETHANOL MODULATES CORONARY PERMEABILITY TO MACROMOLECULES IN MURINE AIDS Alcohol Alcohol., November 1, 2002; 37(6): 555 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Twu, N. Q. Liu, W. Popik, M. Bukrinsky, J. Sayre, J. Roberts, S. Rania, V. Bramhandam, K. P. Roos, W. R. MacLellan, et al. Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways PNAS, October 29, 2002; 99(22): 14386 - 14391. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Raidel, C. Haase, N. R. Jansen, R. B. Russ, R. L. Sutliff, L. W. Velsor, B. J. Day, B. D. Hoit, A. M. Samarel, and W. Lewis Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1672 - H1678. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sarkar, P. Vallance, and S. E. Harding Nitric oxide: not just a negative inotrope Eur J Heart Fail, October 1, 2001; 3(5): 527 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kan, Z. Xie, and M. S. Finkel HIV gp120 enhances NO production by cardiac myocytes through p38 MAP kinase-mediated NF-kappa B activation Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H3138 - H3143. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |